Accéder au contenu
Merck

IgG3 regulates tissue-like memory B cells in HIV-infected individuals.

Nature immunology (2018-08-15)
Lela Kardava, Haewon Sohn, Christine Youn, James W Austin, Wei Wang, Clarisa M Buckner, J Shawn Justement, Valerie A Melson, Gwynne E Roth, Marissa A Hand, Kathleen R Gittens, Richard W Kwan, Michael C Sneller, Yuxing Li, Tae-Wook Chun, Peter D Sun, Susan K Pierce, Susan Moir
RÉSUMÉ

Immunoglobulin G3 (IgG3) has an uncertain role in the response to infection with and vaccination against human immunodeficiency virus (HIV). Here we describe a regulatory role for IgG3 in dampening the immune system-activating effects of chronic HIV viremia on B cells. Secreted IgG3 was bound to IgM-expressing B cells in vivo in HIV-infected chronically viremic individuals but not in early-viremic or aviremic individuals. Tissue-like memory (TLM) B cells, a population expanded by persistent HIV viremia, bound large amounts of IgG3. IgG3 induced clustering of B cell antigen receptors (BCRs) on the IgM+ B cells, which was mediated by direct interactions between soluble IgG3 and membrane IgM of the BCR (IgM-BCR). The inhibitory IgG receptor CD32b (FcγRIIb), complement component C1q and inflammatory biomarker CRP contributed to the binding of secreted IgG3 onto IgM-expressing B cells of HIV-infected individuals. Notably, IgG3-bound TLM B cells were refractory to IgM-BCR stimulation, thus demonstrating that IgG3 can regulate B cells during chronic activation of the immune system.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
IgG3, Kappa from human myeloma plasma, purified immunoglobulin, >90% (microfluidic capillary gel electrophoresis)